[go: up one dir, main page]

BR112013027247A2 - Cepas do vírus da varicela-zóster e vacina contra o vírus da catapora e herpes zóster usando as mesmas - Google Patents

Cepas do vírus da varicela-zóster e vacina contra o vírus da catapora e herpes zóster usando as mesmas

Info

Publication number
BR112013027247A2
BR112013027247A2 BR112013027247A BR112013027247A BR112013027247A2 BR 112013027247 A2 BR112013027247 A2 BR 112013027247A2 BR 112013027247 A BR112013027247 A BR 112013027247A BR 112013027247 A BR112013027247 A BR 112013027247A BR 112013027247 A2 BR112013027247 A2 BR 112013027247A2
Authority
BR
Brazil
Prior art keywords
zoster virus
varicella
same
vaccine
herpes zoster
Prior art date
Application number
BR112013027247A
Other languages
English (en)
Inventor
Hee Kim Geun
Nae Kwon Shi
Hee Lee Chan
Yoon Yeop
Original Assignee
Mogam Biotechnology Res Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mogam Biotechnology Res Institute filed Critical Mogam Biotechnology Res Institute
Publication of BR112013027247A2 publication Critical patent/BR112013027247A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/03—Herpetoviridae, e.g. pseudorabies virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/03—Herpetoviridae, e.g. pseudorabies virus
    • C07K14/04—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

CEPAS DO VÍRUS DA VARICELA-ZÓSTER E VACINA CONTRA O VÍRUS DA CATAPORA E HERPES ZÓSTER USANDO AS MESMAS. A presente invenção refere-se à nova cepa do vírus da Varicela-Zóster e a uma vacina contra o vírus da catapora e herpes zoster usando a mesma. Mais particularmente, a presente invenção refere-se ao DNA genômico da cepa de VZV MAV/06 isolada de um paciente coreano, a um quadro aberto de leitura (ORF) do mesmo, a uma proteína codificada pelo DNA genômico da cepa VZV MAV/06 e o ORF da mesma e a uma composição de vacina que contém a proteína como um ingrediente ativo.
BR112013027247A 2011-02-24 2012-02-24 Cepas do vírus da varicela-zóster e vacina contra o vírus da catapora e herpes zóster usando as mesmas BR112013027247A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161446284P 2011-02-24 2011-02-24
PCT/KR2012/001408 WO2012115474A2 (ko) 2011-02-24 2012-02-24 신규한 수두 대상포진 바이러스주 및 이를 이용한 수두 및 대상포진 바이러스 백신

Publications (1)

Publication Number Publication Date
BR112013027247A2 true BR112013027247A2 (pt) 2017-08-22

Family

ID=46721358

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013027247A BR112013027247A2 (pt) 2011-02-24 2012-02-24 Cepas do vírus da varicela-zóster e vacina contra o vírus da catapora e herpes zóster usando as mesmas

Country Status (9)

Country Link
US (1) US20140147458A1 (pt)
EP (1) EP2679683A4 (pt)
JP (1) JP2014508522A (pt)
KR (1) KR20140022799A (pt)
CN (1) CN103392001A (pt)
BR (1) BR112013027247A2 (pt)
MX (1) MX2013009723A (pt)
RU (1) RU2580003C2 (pt)
WO (1) WO2012115474A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9149521B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9504743B2 (en) 2013-09-25 2016-11-29 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9017698B2 (en) 2013-09-25 2015-04-28 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149522B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
KR102416781B1 (ko) 2015-08-20 2022-07-05 고려대학교 산학협력단 수두 대상포진 바이러스에 의해 유발되는 질병의 치료 또는 예방용 약학 조성물
EP3545972A4 (en) 2016-11-25 2020-05-13 Mogam Institute For Biomedical Research VARICELLA AND ZONA VIRUS VACCINE
WO2018097642A1 (ko) * 2016-11-25 2018-05-31 재단법인 목암생명과학연구소 바리셀라 조스터 바이러스 백신
JP6815521B2 (ja) 2016-12-26 2021-01-20 モガム・インスティテュート・フォー・バイオメディカル・リサーチＭｏｇａｍ Ｉｎｓｔｉｔｕｔｅ Ｆｏｒ Ｂｉｏｍｅｄｉｃａｌ Ｒｅｓｅａｒｃｈ 帯状疱疹ワクチン組成物
WO2019035605A2 (ko) 2017-08-16 2019-02-21 주식회사 차백신연구소 리포펩티드가 삽입된 리포좀을 유효성분으로 포함하는 백신 아쥬반트 및 이의 용도
KR102098097B1 (ko) 2017-08-16 2020-05-26 주식회사 차백신연구소 리포펩티드가 삽입된 리포좀을 유효성분으로 포함하는 백신 아쥬반트 및 이의 용도
CN112189017B (zh) * 2018-05-23 2024-12-27 财团法人牧岩生命科学研究所 水痘带状疱疹病毒的抗原变体及其用途
CN115192703A (zh) * 2021-04-08 2022-10-18 长春百克生物科技股份公司 一种带状疱疹疫苗及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ253527A (en) * 1992-06-04 1996-09-25 Merck & Co Inc Live attenuated varicella zoster virus vaccine production and culturing cells in monolayers
KR0135614B1 (ko) * 1994-11-23 1998-04-23 허영섭 약독화 수두 생바이러스 백신 및 그의 제조방법
US7112331B2 (en) * 1996-02-09 2006-09-26 Smithkline Beecham Biologicals, S.A. Vaccines against varicella zoster virus gene 63 product
US6528066B1 (en) * 1999-09-14 2003-03-04 University Of Iowa Research Foundation Variant varicella-zoster viruses and methods of use
AU2002951692A0 (en) * 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
EP1721981A4 (en) * 2004-03-05 2007-03-14 Univ Osaka Res Found RECOMBINANT VARICELLA ZOSTER VIRUS
AU2005338519B2 (en) * 2005-11-24 2011-06-16 National Institute Of Biomedical Innovation Recombinant polyvalent vaccine

Also Published As

Publication number Publication date
US20140147458A1 (en) 2014-05-29
MX2013009723A (es) 2013-09-16
KR20140022799A (ko) 2014-02-25
WO2012115474A2 (ko) 2012-08-30
EP2679683A2 (en) 2014-01-01
RU2013143146A (ru) 2015-03-27
CN103392001A (zh) 2013-11-13
JP2014508522A (ja) 2014-04-10
WO2012115474A3 (ko) 2012-11-22
EP2679683A4 (en) 2015-07-15
RU2580003C2 (ru) 2016-04-10

Similar Documents

Publication Publication Date Title
BR112013027247A2 (pt) Cepas do vírus da varicela-zóster e vacina contra o vírus da catapora e herpes zóster usando as mesmas
BR112018075465A2 (pt) agentes antivirais de hepatite b
BR112012033689A2 (pt) derivados de ácido 2-quinolinil-acético como compostos de hiv antivirais
EA201690497A2 (ru) Композиции и способы ингибирования экспрессии генов вируса гепатита в
CY1119058T1 (el) Ενωσεις ιμιδαζοπυρρολιδινονης
BR112018067964A2 (pt) agentes antivirais para hepatite b
CY1118246T1 (el) Αναστολεις αντιγραφης ιων γριπης
BR112015014457A2 (pt) composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c
WO2016061232A3 (en) Multiplexed shrnas and uses thereof
BR112016013387A2 (pt) composições e métodos para controle de vírus em ácaros varroa e abelhas
MY202109A (en) Viral replication inhibitors
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
UA116083C2 (uk) Похідні пурину для лікування вірусних інфекцій
GT201300293A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina.
BR112014015016A8 (pt) Proteína homodimérica de duas cadeias de aminoácidos idênticas, cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica, célula hospedeira, método de preparação de uma proteína homodimérica, método para preparação de uma vacina, vacina e método de tratamento ou prevenção
MX2010009563A (es) Compuestos quimicos con accion antiviral contra virus de dengue y otros flavivirus.
AU2016229966A8 (en) Beta-D-2'-deoxy-2'alpha-fluoro-2'-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
BR112015010791A2 (pt) moduladores de gpr40 de di-hidropirazol
MY194294A (en) Novel viral replication inhibitors
MX350282B (es) Molecula de union que tiene actividad neutralizadora del virus de la influenza a, producida a partir de celulas b humanas.
MX354676B (es) Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv).
NZ702146A (en) Peptides derived from viral proteins for use as immunogens and dosage reactants
PH12014501388A1 (en) A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv
BR112014015582A8 (pt) compostos antivirais
MA32305B1 (fr) Vaccin contre le virus vivant attenue inactive de la fievre catarrhale ovine

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]